| Nov 20 |
Weight loss drug makers want more insurance plans to cover Wegovy and Zepbound
|
| Nov 20 |
China-based biotech Laekna teams up with Lilly to develop muscle preserving obesity drug
|
| Nov 20 |
Eli Lilly Option Trade Produces $1,125, If You Can Tolerate The Heavy Risk
|
| Nov 20 |
Is It Time to Sell Eli Lilly and Pfizer Stocks?
|
| Nov 20 |
Verge Genomics Announces Milestones in Collaboration with Lilly to Discover and Develop Novel Treatments for ALS
|
| Nov 20 |
The Zacks Analyst Blog Highlights Eli Lilly, PepsiCo and Morgan Stanley
|
| Nov 20 |
RFK Jr. Sparks New Worries About Obesity Drugs. Here’s What Investors Should Focus on Instead.
|
| Nov 19 |
Lilly announces changes on board of directors
|
| Nov 19 |
Top Research Reports for Eli Lilly, PepsiCo & Morgan Stanley
|
| Nov 19 |
LLY Oral Cholesterol Drug Lowers Lipoprotein Levels in Phase II Study
|
